WHO monographs on selected medicinal plants - travolekar.ru

WHO monographs on selected medicinal plants - travolekar.ru WHO monographs on selected medicinal plants - travolekar.ru

20.01.2015 Views

ong>WHOong> ong>monographsong> on selected medicinal plants decreased coronary vascular resistance in a dose-dependent manner (p < 0.01) (34). Magnolol (concentration 10–100 μg/ml) inhibited norepinephrine-induced phasic and tonic contractions in rat thoracic aorta in vitro (35). Miscellaneous activities Honokiol and magnolol increase choline acetyl-transferase activity, inhibit acetylcholinesterase, promote potassium-induced acetylcholine release and exhibit neurotrophic function in vitro. In conscious, freelymoving rats a dose of honokiol or magnolol (10 -4 –10 -6 M) was perfused into the hippocampus via a dialysis probe. The results showed that at a dose of 10 -4 M honokiol or magnolol markedly increased extracellular acetylcholine release to 165.5% and 237.83% of the basal level, respectively. However, lower concentrations of either compound failed to elicit significant acetylcholine release (36). The effects of magnolol on thermoregulation and hypothalamic release of 5-hydroxytryptamine were assessed in normothermic rats and in febrile rats treated with interleukin-1 beta. Intraperitoneal administration of magnolol (25.0–100.0 mg/kg bw) produced a decrease in colon temperature, an increase in foot skin temperature, a decrease in metabolic rate and a decrease in the endogenous release of 5-hydroxytryptamine in the rat hypothalamus. Depletion of 5-hydroxytryptamine in rat brain, produced by intracerebroventricular pretreatment with 5,7-dihydroxytryptamine, attenuated the magnolol-induced hypothermia and cutaneous vasodilation, and decreased metabolism (37). Muscle relaxation effects Intraperitoneal administration of an ether extract of the crude drug, at a dose of 1.0 g/kg bw induced a loss of the righting reflex 30 minutes after injection. In mice, intraperitoneal administration of magnolol (50.0– 500.0 mg/kg bw) produced sedation, ataxia, muscle relaxation and a loss of righting reflex. Intraperitoneal administration of magnolol and honokiol (50.0 mg/kg bw) to young chicks suppressed spinal reflexes (38–40). Toxicity The median lethal dose after intraperitoneal injection of a decoction is 6 g/kg bw in mice, and the median lethal dose is 4.25 g/kg bw in cats after intravenous administration (19, 34). Clinical pharmacology No information was found for single-entity preparations of Cortex Magnoliae. 174

Cortex Magnoliae Contraindications Hypersensitivity or allergy to the plant material. Warnings No information was found. Precautions General No information was found. Drug interactions None reported. Drug and laboratory test interactions None reported. Carcinogenesis, mutagenesis, impairment of fertility An aqueous extract of the bark was not mutagenic in the Ames test in Salmonella typhimurium strains TA98 and TA100 at concentrations up to 40.0 mg per agar plate (41). Magnolol at concentrations of 10 -9 and 10 -7 M reduced ferrous sulfate-induced lipid peroxidation and reduction in sperm motility and protected sperm from lipid peroxidation in vitro (42). Pregnancy: teratogenic effects None reported. Pregnancy: non-teratogenic effects Due to a lack of safety data the use of the crude drug during pregnancy is not recommended. Nursing mothers Due to a lack of safety data the use of the crude drug during breastfeeding is not recommended. Paediatric use Due to a lack of safety data the use of the crude drug in children under the age of 12 years is not recommended. Adverse reactions No information was found. 175

<str<strong>on</strong>g>WHO</str<strong>on</strong>g> <str<strong>on</strong>g>m<strong>on</strong>ographs</str<strong>on</strong>g> <strong>on</strong> <strong>selected</strong> <strong>medicinal</strong> <strong>plants</strong><br />

decreased cor<strong>on</strong>ary vascular resistance in a dose-dependent manner<br />

(p < 0.01) (34). Magnolol (c<strong>on</strong>centrati<strong>on</strong> 10–100 μg/ml) inhibited norepinephrine-induced<br />

phasic and t<strong>on</strong>ic c<strong>on</strong>tracti<strong>on</strong>s in rat thoracic aorta in<br />

vitro (35).<br />

Miscellaneous activities<br />

H<strong>on</strong>okiol and magnolol increase choline acetyl-transferase activity, inhibit<br />

acetylcholinesterase, promote potassium-induced acetylcholine release<br />

and exhibit neurotrophic functi<strong>on</strong> in vitro. In c<strong>on</strong>scious, freelymoving<br />

rats a dose of h<strong>on</strong>okiol or magnolol (10 -4 –10 -6 M) was perfused<br />

into the hippocampus via a dialysis probe. The results showed that at a<br />

dose of 10 -4 M h<strong>on</strong>okiol or magnolol markedly increased extracellular<br />

acetylcholine release to 165.5% and 237.83% of the basal level, respectively.<br />

However, lower c<strong>on</strong>centrati<strong>on</strong>s of either compound failed to elicit<br />

significant acetylcholine release (36).<br />

The effects of magnolol <strong>on</strong> thermoregulati<strong>on</strong> and hypothalamic release<br />

of 5-hydroxytryptamine were assessed in normothermic rats and in febrile<br />

rats treated with interleukin-1 beta. Intraperit<strong>on</strong>eal administrati<strong>on</strong> of magnolol<br />

(25.0–100.0 mg/kg bw) produced a decrease in col<strong>on</strong> temperature, an<br />

increase in foot skin temperature, a decrease in metabolic rate and a decrease<br />

in the endogenous release of 5-hydroxytryptamine in the rat hypothalamus.<br />

Depleti<strong>on</strong> of 5-hydroxytryptamine in rat brain, produced by<br />

intracerebroventricular pretreatment with 5,7-dihydroxytryptamine, attenuated<br />

the magnolol-induced hypothermia and cutaneous vasodilati<strong>on</strong>,<br />

and decreased metabolism (37).<br />

Muscle relaxati<strong>on</strong> effects<br />

Intraperit<strong>on</strong>eal administrati<strong>on</strong> of an ether extract of the c<strong>ru</strong>de d<strong>ru</strong>g, at a<br />

dose of 1.0 g/kg bw induced a loss of the righting reflex 30 minutes after<br />

injecti<strong>on</strong>. In mice, intraperit<strong>on</strong>eal administrati<strong>on</strong> of magnolol (50.0–<br />

500.0 mg/kg bw) produced sedati<strong>on</strong>, ataxia, muscle relaxati<strong>on</strong> and a loss<br />

of righting reflex. Intraperit<strong>on</strong>eal administrati<strong>on</strong> of magnolol and h<strong>on</strong>okiol<br />

(50.0 mg/kg bw) to young chicks suppressed spinal reflexes (38–40).<br />

Toxicity<br />

The median lethal dose after intraperit<strong>on</strong>eal injecti<strong>on</strong> of a decocti<strong>on</strong> is<br />

6 g/kg bw in mice, and the median lethal dose is 4.25 g/kg bw in cats after<br />

intravenous administrati<strong>on</strong> (19, 34).<br />

Clinical pharmacology<br />

No informati<strong>on</strong> was found for single-entity preparati<strong>on</strong>s of Cortex<br />

Magnoliae.<br />

174

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!